Skip to main content

EOS Biotechnology, Incyte Genomics, Surmodics


EOS Biotechnology of South San Francisco received US Patent No. 6,516,276, “Method and apparatus for analysis of data from biomolecular arrays.” The patent covers an application for analyzing data from biomolecular binding experiments that collects data from probes and generates probability values on bindng success. Normalized values are generated and data is ouput incuding normalized values and probablility values for the array probe sets.

Incyte Genomics of Palo Alto, Calif., received US Patent No. 6,514,751, “Linear microarrays.” The patent provides a method for detecting the presence of polynucleotide sequence in a sample. The system uses volumes in the range of 10 nanoliters to 10 microliters for sample delivery, hybridization, or washes. It is constructed of capillary-like casings, with input and output openings, and a substrate immobilized in each of the casings.

Surmodics of Eden Prairie, Minn., received US Patent No. 6,514,768, “Replicable probe array.” The patent covers a system for producing nucleic acid-based arrays by replicating an original master array, or providing a reusable assay capable of being regenerated.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.